CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.

Br J Cancer 2016 Jan 14;114(2):221-9. Epub 2016 Jan 14.

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Background: Menopausal hormone therapy (MHT) use has been consistently associated with a decreased risk of colorectal cancer (CRC) in women. Our aim was to use a genome-wide gene-environment interaction analysis to identify genetic modifiers of CRC risk associated with use of MHT.

Methods: We included 10 835 postmenopausal women (5419 cases and 5416 controls) from 10 studies. We evaluated use of any MHT, oestrogen-only (E-only) and combined oestrogen-progestogen (E+P) hormone preparations. To test for multiplicative interactions, we applied the empirical Bayes (EB) test as well as the Wald test in conventional case-control logistic regression as primary tests. The Cocktail test was used as secondary test.

Results: The EB test identified a significant interaction between rs964293 at 20q13.2/CYP24A1 and E+P (interaction OR (95% CIs)=0.61 (0.52-0.72), P=4.8 × 10(-9)). The secondary analysis also identified this interaction (Cocktail test OR=0.64 (0.52-0.78), P=1.2 × 10(-5) (alpha threshold=3.1 × 10(-4)). The ORs for association between E+P and CRC risk by rs964293 genotype were as follows: C/C, 0.96 (0.61-1.50); A/C, 0.61 (0.39-0.95) and A/A, 0.40 (0.22-0.73), respectively.

Conclusions: Our results indicate that rs964293 modifies the association between E+P and CRC risk. The variant is located near CYP24A1, which encodes an enzyme involved in vitamin D metabolism. This novel finding offers additional insight into downstream pathways of CRC etiopathogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815813PMC
January 2016
42 Reads

Publication Analysis

Top Keywords

crc risk
12
association e+p
8
colorectal cancer
8
cocktail test
8
modifies association
8
identified interaction
8
e+p crc
8
test
6
crc
5
risk
5
rs964293 genotype
4
wald test
4
respectivelyconclusions indicate
4
well wald
4
indicate rs964293
4
rs964293 modifies
4
test well
4
test conventional
4
040 022-073
4
022-073 respectivelyconclusions
4

References

(Supplied by CrossRef)
Article in JAMA
GL Anderson et al.
JAMA 2004
Article in Science
KG Ardlie et al.
Science 2015
Article in Biochem Biophys Res Commun
P Bareis et al.
Biochem Biophys Res Commun 2001
Article in Am J Hum Genet
SR Browning et al.
Am J Hum Genet 2007
Article in Am J Epidemiol
P Bruzzi et al.
Am J Epidemiol 1985
Article in J Natl Cancer Inst
EE Calle et al.
J Natl Cancer Inst 1995
Article in Cancer Causes Control
PT Campbell et al.
Cancer Causes Control 2007
Article in Gastroenterology
AT Chan et al.
Gastroenterology 2010
Article in N Engl J Med
RT Chlebowski et al.
N Engl J Med 2004
Article in Nat Rev Cancer
Ga Colditz et al.
Nat Rev Cancer 2005
Article in Nat Rev Cancer
KK Deeb et al.
Nat Rev Cancer 2007

Similar Publications